Kong et al. [217] used WP1066 to inhibit the JAK2-STAT3 signaling pathway and suppress immunosuppressive FoxP3 + regulatory T cells, achieving therapeutic effects in a melanoma BM model. Here, JAK2 is linked to melanoma.